Cochrane Abstracts
High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High‐dose Chemotherapy Followed By Autologous Stem Cell Transplantation for Patients With Relapsed/refractory Hodgkin Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431922/all/High‐dose_chemotherapy_followed_by_autologous_stem_cell_transplantation_for_patients_with_relapsed_refractory_Hodgkin_lymphoma.
High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431922/all/High‐dose_chemotherapy_followed_by_autologous_stem_cell_transplantation_for_patients_with_relapsed_refractory_Hodgkin_lymphoma. Accessed March 26, 2025.
High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431922/all/High‐dose_chemotherapy_followed_by_autologous_stem_cell_transplantation_for_patients_with_relapsed_refractory_Hodgkin_lymphoma
High‐dose Chemotherapy Followed By Autologous Stem Cell Transplantation for Patients With Relapsed/refractory Hodgkin Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431922/all/High‐dose_chemotherapy_followed_by_autologous_stem_cell_transplantation_for_patients_with_relapsed_refractory_Hodgkin_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
ID - 431922
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431922/all/High‐dose_chemotherapy_followed_by_autologous_stem_cell_transplantation_for_patients_with_relapsed_refractory_Hodgkin_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
